Form 4: Bristol Myers Squibb Executive Reports Stock Transaction
Insider Transaction (Form 4)
Cristian Massacesi, EVP,Chief Med Offr,Head of Dev of Bristol Myers Squibb Co, reported multiple transactions in common stock on August 1, 2026.
Summary
- Option exercise/conversion: acquired 51,172 Common Stock, $0.10 par value on August 1, 2026; holds 51,172 after (Direct).
- Tax/exercise-price withholding: disposed of 26,175 Common Stock, $0.10 par value at $65.31 ($1,709,489) on August 1, 2026; holds 24,997 after (Direct).
- Option exercise/conversion: disposed of 51,172 Restricted Stock Units on August 1, 2026; holds 153,519 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Cristian Massacesi — Officer (EVP,Chief Med Offr,Head of Dev)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-01 | Option exercise/conversion | Common Stock, $0.10 par value | 51,172 | — | — | 51,172 |
| 2026-08-01 | Tax/exercise-price withholding | Common Stock, $0.10 par value | 26,175 | $65 | $1.7M | 24,997 |
| 2026-08-01 | Option exercise/conversion | Restricted Stock Units | 51,172 | — | — | 153,519 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-01 | Option exercise/conversion (51,172 shares) |
| 2026-08-01 | Tax/exercise-price withholding (26,175 shares) |
| 2026-08-01 | Option exercise/conversion (51,172 shares) |
Keywords
insider transaction, Form 4, BMY, BRISTOL MYERS SQUIBB CO, neutral, Cristian Massacesi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.